Swinging London

Also on Monday, George Miller of the U.K.'s MRC Epidemiology & Medical Care Unit at St. Bartholomew's Hospital in London was to present results of the latest stage of the Northwick Park Heart study, which was expected to confirm that Shield Diagnostics' (LSE:SDG) Afecta diagnostic provides additional evidence of cardiovascular disease risk. SDG gained 35 percent 452.5p to 610p. SDG's market cap is £124.4 million (US$207 million).

(LSE:SKP; SKYEY) benefited from speculation that the FDA may be on the verge of approving